A Study to Investigate Interleukin-6 (IL-6) and IL-6/Soluble IL-6 Receptor (sIL-6R) Complex Levels in Subjects With Active Inflammatory Bowel Disease

Disease Course in an IBD Cohort in the Era of Biological Treatment

NCT01468090 ·Status: COMPLETED

Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease

NCT02073526 ·Status: COMPLETED

Mucosal Healing Study in Crohn's Disease (CD)

NCT00297648 ·Status: COMPLETED ·Phase: PHASE3

Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)

NCT01218360 ·Status: COMPLETED

The Role of IL-23-Responsive Immune Cell Subsets in Post-Operative Recurrence in Patients With Crohn's Disease.

NCT06006039 ·Status: RECRUITING

A Study of Moderate to Severe Inflammatory Bowel Disease, Including Ulcerative Colitis (UC) and Crohn's Disease (CD)

NCT04873700 ·Status: COMPLETED

Spatially and Temporally Resolving Predictive Biomarkers of Postoperative Recurrence and Complications in Chronic Intestinal Inflammation

NCT06516341 ·Status: RECRUITING

Unveiling the Microbial Impact on Intestinal Fibrosis

NCT06073288 ·Status: NOT_YET_RECRUITING

A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis

NCT04877990 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease

NCT05733845 ·Status: RECRUITING ·Phase: NA

Prediction and Close Monitoring of Postoperative Recurrence by Intestinal Ultrasound After Ileocecal Resection in Crohn's Disease Patients

NCT05713409 ·Status: UNKNOWN

Prospective Multicenter Trial to Determine the Efficacy and Outcome of the UCRI Biomarker Panel and Algorithm to Detect Mucosal Healing in Moderate to Severe Ulcerative Colitis Patients.

NCT04897282 ·Status: UNKNOWN

Immunological Characteristics of Preclinical IBD

NCT05698745 ·Status: RECRUITING

Changing the Future of Intestinal Failure in Intestinal Chronic Inflammation (INT-FAIL)

NCT06777251 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

The Microbial Impact on Intestinal Fibrosis and the Associated Immune Microenvironment in Crohn's Disease

NCT06720961 ·Status: NOT_YET_RECRUITING

Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis

NCT03169894 ·Status: TERMINATED ·Phase: PHASE1

Role of the Chemical Environment in the Pathogenesis of Inflammatory Bowel Disease

NCT03376230 ·Status: TERMINATED

Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD)

NCT01289366 ·Status: COMPLETED

Immune Ablation and Stem Cell Support for Crohn's Disease

NCT00179842 ·Status: WITHDRAWN ·Phase: PHASE2

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

NCT06233461 ·Status: RECRUITING ·Phase: PHASE2

Significance of Ficolin 2 in the Determination of Serological Activity in Chronic Inflammatory Bowel Disease

NCT01473927 ·Status: COMPLETED

Cytokines and Genes in Therapeutic Response in Crohn's Disease

NCT03266471 ·Status: COMPLETED

Can CT Enteroclysis Predict the Outcome of Crohn's Disease

NCT00572780 ·Status: COMPLETED

Role of Altered Intestinal Permeability and Lipopolysaccharide in Thrombotic Risk and Vascular Injury in IBD Patients

NCT06772350 ·Status: NOT_YET_RECRUITING ·Phase: NA

Stratifying Crohn's Using Biomarker Assessment

NCT04321863 ·Status: UNKNOWN